NL-OMON46194招募中不适用
Personalizing therapy of urogenital cancer by metastatic tissue Immune profiling, Organoid culture, and NExt genERation sequencing - PIONEER
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Patients with metastasized bladder cancer or prostate cancer
排除标准
- •- Comorbidity that interferes with the safe removal of extra tissue.
- •- Objection against anonymized storage of tissue for an unlimited period of time.
- •- Objection against disclosure of relevant incidental findings (DNA sequencing).
研究者
相似试验
已完成
不适用
Tailored treatment of prostate cancer by biomarkers: PROCABIOProstate carcinoma1003858810036958prostate cancerNL-OMON33361Erasmus MC, Universitair Medisch Centrum Rotterdam50
招募中
不适用
Personalized Treatment of Urogenital Cancers Depends on the MicrobiomeMicrobial DiseaseNCT03962920Zealand University Hospital28
已完成
不适用
Development of urothelial cancer-Specific mRNA and miRNA Assay in Human Urinary Exosomes and MicrovesiclesBladder CancerJPRN-UMIN000030054Hokkaido University Graduate School of Medicine600
招募中
1 期
Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular Tracers (THUNDER): A Two-part Phase 2/3 TrialProstate cancerCTIS2022-501551-90-00Gasthuiszusters Antwerpen493
已完成
不适用
Focal therapy of localized prostate cancer using mpMRI/TRUS-guided high intensity focused ultrasound (HIFU) technologyC61Malignant neoplasm of prostateDRKS00007105Klinik für Urologie, Universitätsmedizin Mannheim50